NIH to use part of its budget to fund Department of Defense research

The National Institutes of Health (NIH) has entered into a controversial decade-long agreement to transfer a portion of its budget to the Department of Defense. The funds, drawn from the National Institute of Allergy and Infectious Diseases (NIAID), are intended to support the development of medical countermeasures against pandemic influenza and CBRN threats. While the exact financial commitment remains undisclosed, reports suggest the Defense Department sought up to one-third of the NIAID budget, though it may settle for approximately 10 percent. The move has drawn scrutiny as the NIH is redirecting funds toward projects previously rejected by its own leadership. This reallocation occurs amidst significant strain on the U.S. defense budget due to ongoing geopolitical conflicts and follows reports that the NIH has struggled to fully distribute its congressionally allocated grants. The agreement highlights a notable shift in federal research priorities and inter-agency resource management.